BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36412571)

  • 41. Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
    Colgan TJ; McLachlin CM; Cotterchio M; Howlett R; Seidenfeld AM; Mai VM
    Cancer; 2004 Dec; 102(6):362-7. PubMed ID: 15481083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liquid-based cytology versus conventional cytology for evaluation of cervical Pap smears: experience from the first 1000 split samples.
    Singh VB; Gupta N; Nijhawan R; Srinivasan R; Suri V; Rajwanshi A
    Indian J Pathol Microbiol; 2015; 58(1):17-21. PubMed ID: 25673585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
    Renshaw AA; Mody DR; Wang E; Haja J; Colgan TJ;
    Arch Pathol Lab Med; 2006 Mar; 130(3):332-6. PubMed ID: 16519560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials.
    Castle PE; Bulten J; Confortini M; Klinkhamer P; Pellegrini A; Siebers AG; Ronco G; Arbyn M
    BJOG; 2010 Aug; 117(9):1067-73. PubMed ID: 20604775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pap test in a high-risk population comparison of conventional and liquid-base cytology.
    Utagawa ML; Pereira SM; Makabe S; Maeda MY; Marques JA; Santoro CL; Di Loreto C; Aguiar LS; Pitolli JE; Das Dores GB; Castelo A; Longatto Filho A
    Diagn Cytopathol; 2004 Sep; 31(3):169-72. PubMed ID: 15349987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic importance of women with squamous cell carcinoma cytology on Siriraj liquid-based cervical cytology.
    Ruengkhachorn I; Laiwejpithaya S; Leelaphatanadit C; Chaopotong P
    Asian Pac J Cancer Prev; 2012; 13(9):4567-70. PubMed ID: 23167381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
    Hutchinson ML; Zahniser DJ; Sherman ME; Herrero R; Alfaro M; Bratti MC; Hildesheim A; Lorincz AT; Greenberg MD; Morales J; Schiffman M
    Cancer; 1999 Apr; 87(2):48-55. PubMed ID: 10227593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
    Gao FF; Austin RM; Zhao C
    Cancer Cytopathol; 2011 Dec; 119(6):377-86. PubMed ID: 21774093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of self-sampled HPV test in comparison with liquid based cytology.
    Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT; Sideri M
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():72-6. PubMed ID: 24768230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
    Whitlock EP; Vesco KK; Eder M; Lin JS; Senger CA; Burda BU
    Ann Intern Med; 2011 Nov; 155(10):687-97, W214-5. PubMed ID: 22006930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
    Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
    Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of liquid-based cytology: comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts.
    Confortini M; Bergeron C; Desai M; Negri G; Dalla Palma P; Montanari G; Pellegrini A; Ronco G;
    Cancer Cytopathol; 2010 Aug; 118(4):203-8. PubMed ID: 20731006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
    Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
    Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
    Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
    Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pregnancy related cervical cytological changes and clinical management].
    Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
    Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
    Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.
    Rebolj M; Rask J; van Ballegooijen M; Kirschner B; Rozemeijer K; Bonde J; Rygaard C; Lynge E
    Br J Cancer; 2015 Nov; 113(9):1259-74. PubMed ID: 26448176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Menstrual Cycle on Various Morphologies of High-Grade Squamous Intraepithelial Lesions in SurePath™ Liquid-Based Cervical Cytology.
    Okodo M; Okayama K; Tsukakoshi N; Misawa Y; Tanabe K; Teruya K; Ito C; Ishii Y; Fujii M; Oda M
    Acta Cytol; 2022; 66(6):507-512. PubMed ID: 35700714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.